From Dupixent to Tezspire and verekitug, explore emerging sinusitis treatments and the race to improve chronic rhinosinusitis ...
Early Phase I data showed inhaled londamocitinib reduced airway inflammation in mild asthma with good tolerability. Learn ...
Treatments for are allergic fungal rhinosinusitis, bipolar I disorder, Hunter syndrome, Leber hereditary optic neuropathy, ovarian cancer, and schizophrenia under review.
Money Talks News on MSN
Study: Your nasal spray might prevent COVID
German study reveals common allergy nasal spray reduced Covid infections by 70% compared to placebo group ...
In The Lancet Respiratory Medicine, Christine R Jenkins and colleagues present the results of the Bisoprolol to Prevent Adverse Cardiac Events (PACE) study in chronic obstructive pulmonary disease ...
GlaxoSmithKline (GSK) has agreed to acquire Rapt Therapeutics for $2.2 billion, the companies said today, in a deal intended to bolster the buyer’s pipeline with Rapt’s ozureprubart (RPT904), a ...
Investor's Business Daily on MSN
GSK digs in on allergies with $2.2 billion Rapt Therapeutics buyout
GSK is buying Rapt Therapeutics for $2.2 billion, the companies said Tuesday. Rapt stock rocketed.
RAPT Therapeutics, Inc. is being acquired by GSK plc for $2.2B as ozureprubart targets IgE disorders with 8–12 week dosing.
Cohort 4 data demonstrated positive safety and efficacy results, including additional clinical benefit observed following ...
HealthDay News — For peanut oral immunotherapy (P-OIT), a 30-mg maintenance dose increases the threshold over strict avoidance, according to a study published online Oct. 16 in the Journal of Allergy ...
Metformin makes it easier for women with the hormone disorder PCOS to get pregnant, and the mother often gets better ...
Find out more about how ALA-DAG oil improved skin hydration, reduced allergy symptoms, and may support wider health benefits.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results